New insider activity at Thermo Fisher ( (TMO) ) has taken place on December 4, 2025.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Michel Lagarde, the Executive Vice President and Chief Operating Officer of Thermo Fisher, has recently executed a significant transaction by selling 62,000 shares of the company’s stock. This sale amounted to a substantial $36,126,126.
Recent Updates on TMO stock
In the past 24 hours, Thermo Fisher’s stock has seen notable developments, with Morgan Stanley and HSBC both adjusting their price targets to $670. Morgan Stanley’s analyst Kallum Titchmarsh initiated coverage with an Overweight rating, citing emerging bright spots in the Life Science Tools and Diagnostics market and numerous catalysts in the pipeline. Despite a recent industry valuation spike, the firm maintains an In-Line industry view. HSBC upgraded Thermo Fisher to Buy from Hold, aligning with the $670 price target. These changes reflect optimism about Thermo Fisher’s market position and potential growth opportunities.
Spark’s Take on TMO Stock
According to Spark, TipRanks’ AI Analyst, TMO is a Outperform.
Thermo Fisher’s strong financial performance and positive earnings call are the most significant factors driving the score. The company’s robust profitability and strategic initiatives, such as collaborations and acquisitions, support its growth outlook. However, technical indicators suggest the stock may be overbought, and the high P/E ratio indicates potential overvaluation, which tempers the overall score.
To see Spark’s full report on TMO stock, click here.
More about Thermo Fisher
YTD Price Performance: 11.89%
Average Trading Volume: 2,048,379
Technical Sentiment Signal: Buy
Current Market Cap: $218B